Structure Info
- Chemspace ID
- CSSS00161188829 (In-Stock Screening Compounds)
- MFCD
- MFCD32201037, MFCD01750263
- IUPAC Name
- (4aS,6aR,6bR,8aR,12aR,12bR,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-N-(2,2,2-trifluoroethyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,12b,13,14,14a,14b-icosahydropicene-4a-carboxamide
- Mol formula
- C33H45F3N2O3
- Mol weight
- 575 Da
- Catalog Number(s)
- AA01V4GG, AG01V4J8, AR01V588, BF31628, CSC161188829, F96102, HY-112671, LAN-B70659, M23361, MS-30351, T13604, Y1299685, Y226475
- Zoom the structure
- CSSS00161188829
Items Overall 20 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | 10 days | United States To: | 99 | 5 mg | 190 | |
| MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 240 | |
Description: Names: CDDO-dhTFEA; RTA dh404; Product Description: CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB . CDDO-dhTFEA restores hypertension (MAP), increases Nrf2 and expression of its target genes, attenuates activation of NF-κB and transforming growth factor-β pathways, and reduces glomerulosclerosis, interstitial fibrosis and inflammation in the chronic kidney disease (CKD) rats .; Target: Keap1-Nrf2;NF-κB; CAS: 1191265-33-4 | ||||||
Show all items | ||||||
| MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 200 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 253 | |
Description: Names: CDDO-dhTFEA; RTA dh404; Product Description: CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB CDDO-dhTFEA restores hypertension (MAP), increases Nrf2 and expression of its target genes, attenuates activation of NF-κB and transforming growth factor-β pathways, and reduces glomerulosclerosis, interstitial fibrosis and inflammation in the chronic kidney disease (CKD) rats; Target: Apoptosis;Keap1-Nrf2;NF-κB; CAS: 1191265-33-4 | ||||||
Show all items | ||||||
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 1 mg | 64 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 500 mg | 2,170 | |
Description: CDDO-dhTFEA, a synthetic oleanane triterpenoid, effectively activates Nrf2 while inhibiting the NF-κB pro-inflammatory transcription factor. It restores mean arterial pressure (MAP), elevates Nrf2 levels and the expression of related genes, attenuates NF-κB and transforming growth factor-β pathway activation, and mitigates glomerulosclerosis, interstitial fibrosis, and inflammation in rats with chronic kidney disease (CKD).; CAS: 1191265-33-4 | ||||||
Show all items | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire